Zentalis Pharmaceuticals
ZNTL
ZNTL
145 hedge funds and large institutions have $314M invested in Zentalis Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+3
Holders Change %
+2.11%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
26
Increased
56
Reduced
42
Closed
21
Calls
$262K
Puts
$48K
Net Calls
+$214K
Net Calls Change
-$893K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$23.1M |
| 2 |
DC
2
Decheng Capital
Menlo Park,
California
|
$12.6M |
| 3 |
3
Morgan Stanley
New York
|
$7.98M |
| 4 |
4
Two Sigma Investments
New York
|
$4.3M |
| 5 |
5
Two Sigma Advisers
New York
|
$3.26M |
